Tyrocidine A1, TrcA1

General Information


DRACP ID  DRACP02269

Peptide Name   Tyrocidine A1, TrcA1

Sequence  VKLfPFfNQY

Sequence Length  10

UniProt ID  Not available

PubChem CID  45485347 

Origin  Bacillus aneurinolyticus; Bacillus brevis

Type  Native peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma LC50=15 µM Resazurin assay 24 h 1
A549 Lung adenocarcinoma Carcinoma LC50=12 µM Resazurin assay 24 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=4.1 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Val1<--->Tyr10

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  f=D-Phe

Chiral  Mix



Physicochemical Information


Formula  C49H69N11O10

Absent amino acids  ACDEGHIMRSTW

Common amino acids  FKLNPQVY

Mass  113286

Pl  9.3

Basic residues  1

Acidic residues  0

Hydrophobic residues  3

Net charge  1

Boman Index  -593

Hydrophobicity  -30

Aliphatic Index  68

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  165.56

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17462586

Title  Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis

Doi 10.1016/j.bbamem.2007.01.015

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPN_6090

DRACP is developed by Dr.Zheng's team.